Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology
Disease Category: Bipolar Disorders
Trial Information
National Pregnancy Registry for Atypical Antipsychotics
If you are a pregnant woman between the ages of 18 and 45 and are currently treated with one or more of the following atypical antipsychotics:
•Abilify (aripiprazole)
•Clozaril (clozapine)
•Geodon (ziprasidone)
•Invega (paliperidone)
•Risperdal (risperidone)
•Seroquel (quetiapine)
•Zyprexa (olanzapine)
Register now by calling 1-866-961-2388 and help make the future better for many other women just like you…
This study will involve 3 brief phone interviews over an 8-month period.
The National Pregnancy Registry for Atypical Antipsychotics is dedicated to evaluating the safety of atypical antipsychotic medications that may be taken by women during pregnancy to treat a wide range of mood, anxiety, or psychiatric disorders. The primary goal of this Registry is to determine the frequency of major malformations, such as heart defects, cleft lip, or neural tube defects, in infants exposed to atypical antipsychotics during pregnancy.
For more information, please call 1-866-961-2388.
Stephanie D Connors
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Phone: 617-724-6989
EMail: sdconnors@partners.org
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
